Helix BioMedix, Inc. (OTCPK: HXBM)
Health Care · Biotechnology · US
$3.29
-34.20% today · +17.9% 1Y
Helix BioMedix, Inc. (OTCPK: HXBM) operates in the Biotechnology industry within the Health Care sector. The company is valued at $739.29K and employs 8 people.
Over the last twelve months the share price has gained 17.9%, trading between 1.00 and 6.50.
Tweenvest scores Helix BioMedix, Inc. across four factors: quality 46/100, value 47/100. Its strongest factor is value.
HXBM price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $739.29K
- Revenue (TTM)
- $2.07M
- P/E
- —
- EPS
- -15.59
- Dividend yield
- —
- Beta (5Y)
- 1.75
- 52-week high
- $6.50
- 52-week low
- $1.00
- Avg volume (3M)
- —
- Shares outstanding
- 224.71K
- Employees
- 8
- Next earnings
- —
About Helix BioMedix, Inc.
Helix BioMedix, Inc. is a biopharmaceutical company, which focuses on drug development for treatment of rare dermatological diseases, such as Xeroderma Pigmentosum. The company was founded in 1988 and is headquartered in Bothell, WA.
- ISIN
- US4232875074
- Founded
- 1988
- Listed since
- Mar 25, 1999
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| CERo Therapeutics Holdings, Inc.OTCPK: CERO | $797.17K | $0.01 | -4.55% |
| Hindustan Bio Sciences LimitedBSE: 532041 | $782.54K | Rs7.35 | +1.80% |
| Mosaic ImmunoEngineering, Inc.OTCPK: CPMV | $765.49K | $0.11 | +73.28% |
| Scinai Immunotherapeutics Ltd.NasdaqCM: SCNI | $758.13K | $1.21 | -9.02% |
| Smart Agro - LimitedTASE: SMAG | $734.53K | ₪0.54 | +1.12% |
| Nutra Pharma Corp.OTCPK: NPHC | $715.97K | $0.00 | +9900.00% |
| MindBio Therapeutics Corp.CNSX: MBIO | $715.26K | CA$0.14 | -26.32% |
| SQZ Biotechnologies CompanyOTCPK: SQZB | $707.79K | $0.02 | -0.41% |
Figures last refreshed Oct 4, 2026.